-
Mashup Score: 0Time Saving Tips for using Social Media - 14 hour(s) ago
Time Saving Tips for using Social Media
Source: www.wiley.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Editor, Advanced [Oncology] - 3 day(s) ago
Editor –Â Advanced Sciences (Oncology) Location: Beijing or Shanghai, China or remote in UK Our mission is to unlock human potential. We welcome you for who you are, the background you bring, and we embrace individuals who get excited about
Source: careers.wiley.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5
MONDAY, July 15, 2024 (HealthDay News) — For patients with private insurance undergoing diagnostic testing after prostate-specific antigen (PSA)-based screenin
Source: www.healthday.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Half of cancer deaths could have been prevented through lifestyle changes, says American Cancer Society report - 10 day(s) ago
As many as 40% of cancer cases — and up to half of cancer-related deaths — could have been prevented, according to a new study from the American Cancer Society. Doctors shared thoughts.
Source: www.foxnews.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3
Menin inhibitors constitute a new genre of agents targeting the underlying biology of NPM1-mutant and KMT2A-rearranged acute leukemia by disrupting the interaction between the KMT2A and menin proteins, which then forces the leukemia cells to differentiate into normal cells. Preclincal studies and early clinical trials of menin inhibitors in the treatment of acute myeloid leukemia (AML) have shown strong results. Because there are few targeted therapies for AML, the development of menin inhibitors and the resulting outcomes for patients are exciting. But a lot of unknowns still exist. In this Drawing First Blood webinar, experts will discuss many of the questions surrounding the development and use of menin inhibitors, such as: • Is the hype surrounding menin inhibitors justified given the results that have come out of clinical trials? • Can menin inhibitors be used in other biological subsets of acute leukemia other than the ones being studied? • Will menin inhibitors be a standalone t
Source: events.bizzabo.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4
The survival of patients with metastatic non–small cell lung cancer has significantly improved since the introduction of immunotherapy in 2015. Via the Surveillance, Epidemiology, and End Results dat…
Categories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Using Genomics and BTK Inhibitors in the Treatment of Waldenström Macroglobulinemia | ASH Clinical News | American Society of Hematology - 15 day(s) ago
Mutations underlying Waldenström macroglobulinemia (WM) have increasingly been recognized for impacting disease presentation, prognostication, and treatment outcomes, particularly with Bruton tyrosine kinase inhibitors (BTKis). 1 Mutations in MYD88 and CXCR4 are common in WM, with an incidence of 95-97% and 30-40%, respectively. Nearly all MYD88 mutations are the result of the L265P variant and are ideally assessed through allele-specific polymerase chain reaction. Mutated MYD88 upregulates and activates
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0How to Perfect the Introduction for your Research Article - 23 day(s) ago
An easy-to-use guide on how to write an introduction for a research article.
Source: www.wiley.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Which Inhibitor Should Be Used to Treat FLT3-Positive AML? | ASH Clinical News | American Society of Hematology - 26 day(s) ago
Emma Yasinski is a science and medical journalist based in South Florida. The use and array of FLT3 inhibitors continues to mature and proliferate as 2023 brought another landmark phase III clinical trial of an upfront FLT3 inhibitor and another in the post-transplant setting. With two prospective trials of two different FLT3 inhibitors — midostaurin and quzartinib — in combination with induction chemotherapy showing significant improvements in survival, there is no longer a question of whether to
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1How to Write a Scientific Abstract for Your Research Article | Parts of a Research Article - 1 month(s) ago
Find helpful tips about how to write an abstract for a scientific research journal article.
Source: www.wiley.comCategories: General Medicine News, Oncologists1Tweet
Are you using social media to share your research? We've got 14 #ResearcherTips to boost your online presence. Try them out đź”— https://t.co/9yKwwpbb6v https://t.co/4GQ9vfMgQi